| 45.98 BATS BZX Real-Time Price As of 12:31pm ET |  +1.11 / +2.47%Today’s Change | 36.28 Today|||52-Week Range 95.93 | +18.66% Year-to-Date |
| Previous close | 44.87 |
| Today’s open | 44.91 |
| Day’s range | 44.86 - 46.06 |
| Volume | 43,981 |
| Average volume (3 months) | 1,727,117 |
| Market cap | $8.3B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -6.76% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -6.34% |
| P/E ratio | 53.0 |
| Price/Sales | 2.51 |
| Price/Book | 1.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGENSeattle Genetics Inc | +1.07 | +1.50% |
| JAZZJazz Pharmaceuticals... | +1.64 | +1.29% |
| SRPTSarepta Therapeutics... | +0.17 | +0.14% |
| IONSIonis Pharmaceutical... | -0.61 | -1.06% |
| Next reporting date | February 14, 2019 |
| EPS forecast (this quarter) | $1.17 |
| Annual revenue (last year) | $4.9B |
| Annual profit (last year) | $119.6M |
| Net profit margin | 2.42% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Murray S. Kessler |
Executive VP- Global Operations and Supply Chain Ronald Janish |
Corporate headquarters Dublin, Dublin |
